Saturday - February 07, 2026

Category Archives: Science

Key Differences Between DC and VLF High-Voltage Cable Testing from Wrindu

The image is Wrindu DC High-Volatge Tester. High-voltage cable testing is important in ensuring insulation integrity, operational safety, and long-term reliability of power networks. As utilities and maintenance teams increasingly work with XLPE and other modern polymer-insulated cables, engineers are … Continue reading →

Dermatomyositis Treatment Pipeline Shows Strong Momentum as 10+ Pharma Companies in the Race | DelveInsight

DelveInsight’s, “Dermatomyositis Pipeline Insight 2025” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Dermatomyositis pipeline landscape. It covers the Dermatomyositis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Dermatomyositis pipeline therapeutics … Continue reading →

Human Papillomavirus-positive Oropharyngeal Cancer Clinical Trial Pipeline Shows Potential with Active Contributions from 5+ Key Companies | DelveInsight

DelveInsight’s, “Human Papillomavirus-positive Oropharyngeal Cancer Pipeline Insight 2025” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Human Papillomavirus-positive Oropharyngeal Cancer pipeline landscape. It covers the Human Papillomavirus-positive Oropharyngeal Cancer pipeline drug profiles, including clinical and nonclinical … Continue reading →

Acromegaly Clinical Trial Pipeline Gains Momentum: 10+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Acromegaly Pipeline Insight 2025” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in the Acromegaly pipeline landscape. It covers the Acromegaly pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Acromegaly pipeline … Continue reading →

Cannabinoid Agonist Clinical Trial Pipeline Expands as 20+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s, “Cannabinoid Agonist Pipeline Insight 2025” report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Cannabinoid Agonist pipeline landscape. It covers the Cannabinoid Agonist pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Renal Cancer Clinical Trial Pipeline Accelerates as 75+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Renal Cancer Pipeline Insight 2025” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Renal Cancer pipeline landscape. It covers the Renal Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →